Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;127(4):445-465.
doi: 10.1007/s00702-019-02083-z. Epub 2019 Sep 24.

Microbiota: a novel regulator of pain

Affiliations
Review

Microbiota: a novel regulator of pain

Manon Defaye et al. J Neural Transm (Vienna). 2020 Apr.

Abstract

Among the various regulators of the nervous system, the gut microbiota has been recently described to have the potential to modulate neuronal cells activation. While bacteria-derived products can induce aversive responses and influence pain perception, recent work suggests that "abnormal" microbiota is associated with neurological diseases such as Alzheimer's, Parkinson's disease or autism spectrum disorder (ASD). Here we review how the gut microbiota modulates afferent sensory neurons function and pain, highlighting the role of the microbiota/gut/brain axis in the control of behaviors and neurological diseases. We outline the changes in gut microbiota, known as dysbiosis, and their influence on painful gastrointestinal disorders. Furthermore, both direct host/microbiota interaction that implicates activation of "pain-sensing" neurons by metabolites, or indirect communication via immune activation is discussed. Finally, treatment options targeting the gut microbiota, including pre- or probiotics, will be proposed. Further studies on microbiota/nervous system interaction should lead to the identification of novel microbial ligands and host receptor-targeted drugs, which could ultimately improve chronic pain management and well-being.

Keywords: Microbiota; Microbiota/gut/brain axis; Probiotic treatment; Visceral pain.

PubMed Disclaimer

References

    1. Nat Rev Immunol. 2018 Apr;18(4):243-254 - PubMed
    1. Gut. 2006 Feb;55(2):191-6 - PubMed
    1. Neurogastroenterol Motil. 2012 Apr;24(4):376-e172 - PubMed
    1. J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S22-4 - PubMed
    1. Neuroscience. 2015 Apr 2;290:126-37 - PubMed

MeSH terms